PharmaShots

APRIL 28, 2023

Difficile Infection Date: Apr 27, 2023 | Tags: Seres Therapeutics, Nestlé Health Science, Vowst, C.

FDA 56

FDA 56

PharmaShots

MAY 26, 2023

Takeda and HUTCHMED's Fruquintinib Receives Priority Review from the US FDA to Treat Metastatic Colorectal Cancer Date: May 26, 2023 | Tags: Takeda, HUTCHMED, Fruquintinib, Metastatic Colorectal Cancer, Regulatory, Priority Review, US, FDA Gilead Receives EMA’s CHMP Positive Opinion to Extend the Use of Veklury (remdesivir) for COVID-19 Date: (..)

FDA 40

FDA 40

PharmaShots

APRIL 14, 2023

Ocugen Reports Preliminary Results from the P-I/II Trial of OCU400 for the Treatment of Retinitis Pigmentosa and Leber Congenital Amaurosis Date: Apr 14, 2023 | Tags: Ocugen, OCU400, Retinitis Pigmentosa, Leber Congenital Amaurosis, Clinical Trial, P-I/II Trial Candesant Biomedical Receives the US FDA Clearance of Brella SweatControl Patch for Primary (..)

FDA 40

FDA 40

PharmaShots

FEBRUARY 24, 2023

Positive Solid Tumors Date: Feb 23, 2023 | Tags: Keymed, Lepu Biopharma, AstraZeneca, CMG901, Claudin 18.2-Positive Positive Solid Tumors Date: Feb 23, 2023 | Tags: Keymed, Lepu Biopharma, AstraZeneca, CMG901, Claudin 18.2-Positive Positive Solid Tumors Date: Feb 23, 2023 | Tags: Keymed, Lepu Biopharma, AstraZeneca, CMG901, Claudin 18.2-Positive

FDA 40

FDA Vaccines 40

PharmaShots

JUNE 16, 2023

Date: June 12, 2023 | Tags: Novartis, Chinook Therapeutics, Atrasentan, Zigakibart, BION-1301, IgA nephropathy, M&A, ~$3.5B Date: June 12, 2023 | Tags: Novartis, Chinook Therapeutics, Atrasentan, Zigakibart, BION-1301, IgA nephropathy, M&A, ~$3.5B

FDA 40

FDA Labelling 40

PharmaShots

MAY 19, 2023

Alimera Acquires Rights from EyePoint Pharmaceuticals to Commercialise Yutiq in the US Date: May 19, 2023 | Tags: Alimera, EyePoint Pharmaceuticals, Yutiq, Iluvien, chronic non-infectious uveitis, US, Pharma Sobi Reports EMA’s Validation of MAA for Efanesoctocog Alfa to Treat Haemophilia A Date: May 19, 2023 | Tags: Sobi, Efanesoctocog Alfa, (..)

Medical Schools 40

Medical Schools FDA Immunization Vaccines 40

PharmaShots

MAY 12, 2023

Sanofi Reports P-IIIb Trial (HARMONIE) Results of Nirsevimab for the Prevention of Hospitalizations due to RSV-Related LRTD Date: May 12, 2023 | Tags: Sanofi, Nirsevimab, RSV-Related LRTD, Clinical Trial, P-IIIb, HARMONIE Trial G1 Therapeutics Presents Preliminary Results from P-II Trial of Trilaciclib for Triple-Negative Breast Cancer at ESMO 2023 (..)

FDA 40

FDA Chemotherapy Immunization Hospitals 40

PharmaShots

MARCH 31, 2023

PDS Biotech to Initiate P-III Trial (VERSATILE-003) of PDS0101 + Keytruda (pembrolizumab) for Head and Neck Cancer Date: Mar 31, 2023 | Tags: PDS Biotech, PDS0101, Keytruda, pembrolizumab, Head, Neck Cancer, Clinical Trial, P-III, VERSATILE-003 Trial Omega Therapeutics Entered into a Clinical Supply Agreement with Roche to Evaluate OTX-2002 for Hepatocellular (..)

FDA 40

FDA 40

PharmaShots

FEBRUARY 10, 2023

LEO Pharma Reports P-III Trial (DELTA 2) Results of Delgocitinib for Chronic Hand Eczema Date: Feb 10, 2023 | Tags: LEO Pharma, Delgocitinib, Chronic Hand Eczema, Clinical Trial, P-III, DELTA 2 Trial GSK’s Jemperli (dostarlimab-gxly) Receives the US FDA’s Regular Approval for Recurrent or Advanced Mismatch Repair-Deficient Endometrial Cancer (..)

FDA 40

FDA 40

PharmaShots

FEBRUARY 10, 2023

LEO Pharma Reports P-III Trial (DELTA 2) Results of Delgocitinib for Chronic Hand Eczema Date: Feb 10, 2023 | Tags: LEO Pharma, Delgocitinib, Chronic Hand Eczema, Clinical Trial, P-III, DELTA 2 Trial GSK’s Jemperli (dostarlimab-gxly) Receives the US FDA’s Regular Approval for Recurrent or Advanced Mismatch Repair-Deficient Endometrial Cancer (..)

FDA 40

FDA 40

PharmaShots

FEBRUARY 3, 2023

4D Molecular Therapeutics Receives the US FDA’s IND Clearance of 4D-150 for the Treatment of Diabetic Macular Edema Date: Feb 03, 2023 | Tags: 4D Molecular Therapeutics, 4D-150, Diabetic Macular Edema, Regulatory, US, FDA, IND AstraZeneca and Amgen Receive the US FDA’s Approval of Tezspire (tezepelumab) for the Treatment of Severe Asthma (..)

FDA 40

FDA Labelling 40

Med Ed 101

MAY 23, 2018

The F-Tags have been given a little facelift and renumbering. I’m a consultant pharmacist, so I’m going to focus on the changes in Pharmacy Services F-Tags. The pharmacy services F-Tags run between F755-F761. There are now seven possible pharmacy services F-Tags. I’ll […].

40

40

Med Ed 101

APRIL 7, 2019

I feel like I’m still seeing quite a bit of Namenda XR being used. Namenda XR comes in with a price tag of about $500 dollars per month. The generic version of Namenda (memantine) is an immediate release formulation that is probably going to cost less than $50/month. Source When comparing Namenda XR and memantine, […].

40

40

IDStewardship

MAY 13, 2023

It has claimed the tag line “The Antimicrobial Stewardship Meeting.” This list has been sourced from Twitter and I’m in the process of creating it now. Scroll to the bottom of this post for a list of infectious diseases meetings that have been sourced from Twitter.

Communication 130

Communication 130

European Pharmaceutical Review

AUGUST 24, 2022

tag ® , inspired by the unique features of microtubule biology and perfectly suited for DAR 2 and DAR 4 ADCs. Kasper M, Lassak L, Vogl A, et al. Kasper M, Stengl A, Ochtrop P, et al. 5 Thus, the antibody is able to protect the payload from unwanted interactions with circulating proteins and cells. Chemical Science. and Antibody?Drug?Conjugates.

Compounding 85

Compounding Pharmaceutical Companies Pharmaceutical Companies 85

Dr. Jamie Hardy: The Lifestyle Pharmacist

AUGUST 20, 2020

I’m excited to see you share pictures of your plants on social media. Be sure to tag me using the hashtags #FABSQUAD #PlantSquad. The post The FAB Benefits of House Plants appeared first on Dr. Jamie Hardy.

52

52

Pharma Marketing Network

OCTOBER 4, 2020

I’m your host Don Langsdorf our guest today is Vlad Mkrtumyan. Don ( PMN): Yeah and that might be a concern for some folks out there that who’s websites are supported by advertising because you’re relying upon another third-party that can be adding load time to a site when you’re when you’re add tags are loading.

Health and Personal Care Stores 52

Health and Personal Care Stores Packaging 52

Pharmaceutical Technology

APRIL 5, 2023

But access to these treatments continues to remain limited due to high price tags and variable availability across regions. BL: I’m really excited about the first potential CRISPR approval because it represents two elements; the integration of new technology, and the availability in a generally underserved population.

FDA 59

FDA Immunization 59

Viseven

NOVEMBER 30, 2022

The change I’m talking about is the reduced attention span. We create structured, well-categorized content, where we have to tag it manually or automatically, and we create a whole taxonomy structure. The change was already happening if you look at the pharmaceutical customers in general.

52

52

The FDA Law Blog

JUNE 27, 2023

HP&M’s James E. HP&M) is pleased to announce that Law360 has recognized one of our firm’s Directors, James E. HP&M’s Kurt R. Karst Awarded WWL: Life Sciences 2023 Global Elite Thought Leader HP&M Director Kurt R. Gibbs Paul M. Hyman Alan M. Valentine , as a 2023 Rising Star. Dormer Jeffrey N.

FDA 81

FDA 81

The Spirit Pharmacist

DECEMBER 2, 2021

However, psychedelic assisted therapy is resource intensive and will likely come with a price tag putting it out of reach of many persons that could benefit from such therapies. You can make a donation to the fund or apply to receive its benefits using the links below: Donate and Support. Apply and Benefit.

Health and Personal Care Stores 52

Health and Personal Care Stores Insurance Coverage Insurance Patient Care 52

European Pharmaceutical Review

NOVEMBER 10, 2022

BT-474 cell line was gene-edited to incorporate a green fluorescent protein (GFP) tag into late endosomes/lysosomes (green). Tewabe A, Abate A, Tamrie M, Seyfu A, Abdela Siraj E. Dominska M, Dykxhoorn D. M, Lázaro-Ibáñez, E., Physical characterisation. J Multidiscip Healthc. 2021 Jul 5;14:1711-1724. Gunnarsson, A.,

Labelling 98

Labelling Compounding 98

European Pharmaceutical Review

DECEMBER 27, 2023

This is in addition to its considerable price tag. Grupp SA, Kalos M, Barrett D, et al. Zhang H, Liu M, Li Q, et al. The demand for CAR T-cell therapy is therefore much greater than the supply, making it difficult for patients to access the potentially life-saving treatment. Cytotherapy. 2022;24(9):940–53. 2013;368(16):1509–18.

Adverse Reactions 85

Adverse Reactions Immunization Medical Schools Chemotherapy 85

ISPE

JANUARY 9, 2023

For example, based on benchmarking different cases, inserting four additional data points as tags into an existing data store would require an entire week of IT and QA collaboration. Sáez, and M. Krüger, and M. This ad hoc strategy is rigid, expensive, and slow. 1 Tebar, A., Reimagining CPV for a Pharma 4.0™ 3, (May–June 2022).

Documentation 52

Documentation Communication 52

Pharma Marketing Network

JUNE 8, 2020

I mean, you know, there has obviously been a lot of breakthrough biologics and different therapeutics like around cancers and things like that, that have high price tags because maybe they don’t have as big a market as you know, something’s wrong, you know blood pressure medication. So yeah, there is plenty to talk about there.

Health and Personal Care Stores 40

Health and Personal Care Stores Hospitals Mayo Clinic Specialty Pharmacies 40